Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
School of Medicine, Tsinghua University, Beijing, China.
JCI Insight. 2020 Jul 9;5(13):135678. doi: 10.1172/jci.insight.135678.
Acute respiratory distress syndrome (ARDS) results from overwhelming pulmonary inflammation. Prior bulk RNA sequencing provided limited insights into ARDS pathogenesis. We used single cell RNA sequencing to probe ARDS at a higher resolution. PBMCs of patients with pneumonia and sepsis with early ARDS were compared with those of sepsis patients who did not develop ARDS. Monocyte clusters from ARDS patients revealed multiple distinguishing characteristics in comparison with monocytes from patients without ARDS, including downregulation of SOCS3 expression, accompanied by a proinflammatory signature with upregulation of multiple type I IFN-induced genes, especially in CD16+ cells. To generate an ARDS risk score, we identified upregulation of 29 genes in the monocytes of these patients, and 17 showed a similar profile in cells of patients in independent cohorts. Monocytes had increased expression of RAB11A, known to inhibit neutrophil efferocytosis; ATP2B1, a calcium pump that exports Ca2+ implicated in endothelial barrier disruption; and SPARC, associated with processing of procollagen to collagen. These data show that monocytes of ARDS patients upregulate expression of genes not just restricted to those associated with inflammation. Together, our findings identify molecules that are likely involved in ARDS pathogenesis that may inform biomarker and therapeutic development.
急性呼吸窘迫综合征(ARDS)是由肺部炎症过度引起的。先前的大规模 RNA 测序对 ARDS 的发病机制提供了有限的见解。我们使用单细胞 RNA 测序以更高的分辨率探究 ARDS。将肺炎和脓毒症伴早期 ARDS 的患者的 PBMC 与未发生 ARDS 的脓毒症患者的 PBMC 进行比较。与无 ARDS 患者的单核细胞相比,ARDS 患者的单核细胞簇显示出多个不同的特征,包括 SOCS3 表达下调,伴随着多个 I 型 IFN 诱导基因的上调,特别是在 CD16+细胞中。为了生成 ARDS 风险评分,我们在这些患者的单核细胞中鉴定出 29 个基因的上调,其中 17 个在独立队列患者的细胞中表现出类似的特征。单核细胞中 RAB11A、ATP2B1 和 SPARC 的表达增加,RAB11A 已知抑制中性粒细胞吞噬作用,ATP2B1 是一种钙泵,可将 Ca2+输出到与内皮屏障破坏有关的细胞中,SPARC 与前胶原转化为胶原有关。这些数据表明,ARDS 患者的单核细胞上调的基因表达不仅限于与炎症相关的基因。总之,我们的研究结果确定了可能参与 ARDS 发病机制的分子,这可能为生物标志物和治疗方法的开发提供信息。